Biopharmaceuticals Market Statistics with Top Factors which Boost the Industry around the Globe
Biopharmaceuticals Market is expected to touch $526,008 million by 2025, increasing at a CAGR of 13.8% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.
Biopharmaceuticals, also known as biologics, are drugs that are manufactured in living systems, such as microorganisms and animal cells. An array of different biopharmaceuticals is also produced using recombinant DNA technology. The biopharmaceuticals sector is the fastest-growing segment of the pharmaceutical industry.
The report provides an extensive competitive analysis and profiles of the key market players, such as Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Pfizer, Inc., and Sanofi. The other players in the value chain (not included in the report) include Bristol Myers Squibb Company, Bayer AG, and Shire plc.
Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/3971
The global biopharmaceuticals market is anticipated to grow considerably in the near future, owing to various factors, such as strategic collaborations among biopharmaceuticals companies, increase in obesity and sedentary lifestyle among the population, rise in an elderly population, and an upsurge in the prevalence of chronic diseases, such as cancer, globally. However, high costs associated with biopharmaceuticals drug development and a stringent regulatory scenario are key factors expected to impede the market growth. On the contrary, emerging markets, such as India and China, are anticipated to provide lucrative growth opportunities to the market players during the forecast period.
By type, the monoclonal antibody segment accounted for a nearly two-fifths share of the global biopharmaceuticals market in 2017. In terms of application, the oncology segment accounted for a one-third share in 2017 and is projected to exhibit a prominent growth rate, owing to a surge in cancer prevalence globally. By region, North America generated the highest revenue in the global biopharmaceuticals market in 2017.
Key Findings of the Biopharmaceuticals Market:
• The monoclonal antibody segment is anticipated to dominate the global biopharmaceuticals market from 2018 to 2025.
• The metabolic disease application is anticipated to grow with the highest CAGR throughout the forecast period.
• North America accounted for a share of more than two-fifths of the global biopharmaceuticals market in 2017.
• The Asia-Pacific region is anticipated to grow at the highest rate in the global biopharmaceuticals market during the forecast period, followed by LAMEA.
Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/3971
North America held the highest market share in 2017, owing to the high prevalence rate of cancer and other chronic diseases, the adoption of biologics, and an increase in awareness about biopharmaceuticals. The Asia-Pacific region is expected to grow at the highest CAGR of 17.2% during the forecast period, owing to rapid industrialization in the area, an increase in disposable income, and an upsurge in government initiatives to modernize the healthcare infrastructure.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biopharmaceuticals Market Statistics with Top Factors which Boost the Industry around the Globe here
News-ID: 1900960 • Views: 272
More Releases from Allied Market Research
Ultrasonic Air Bubble Detectors Market Size & Share | Analysis - 2026
UPCOMING REPORT’S INTRODUCTION: According to an upcoming report of Allied Market Research, titled, “Ultrasonic Air Bubble Detectors Market”, the Ultrasonic Air Bubble Detectors market is expected to grow sustainably from 2020 to 2027. The report offers a comprehensive analysis of various growth drivers of the Ultrasonic Air Bubble Detectors market. The analysis ranges from revenue and operations to future growth opportunities. This comprehensive analysis of great importance for stakeholders to
World GPS Tracking Device Market - Opportunities and Forecasts, 2020-2027
Analyzing the current situation of pandemic, Allied market research has published a report t, which says, the GPS Tracking Device market is expected to grow at a faster pace by 2027. The researchers have intelligently made analysis and forecasts of the future growth by taking the past performance and data into consideration. The analysis offered by the report will surely provide valuable insights to the stakeholders of the GPS Tracking
Automotive Smart Helmet Market Statistics 2020: Advanced Technologies, Trends, C …
Allied Market Research published a new report, titled, "Automotive Smart Helmet Market." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. Get detailed COVID-19 impact
Hybrid Funds Market Size, Share and Growth | Analysis - 2027
INTRODUCTION TO REPORT The report published by Allied market research, titled, “Hybrid Funds Market”, offers a comprehensive analysis of key growth drivers, key segments, development strategies, market opportunities, and competitive landscape. This study offers detailed insights for market players, investors, stakeholders, and new entrants to understand the industry dynamics and determine strategic steps to gain the competitive advantage. COVID_19 Scenarios: The Hybrid Funds has been the worst hit by COVID-19 globally. Based
More Releases for Biopharmaceuticals
Biopharmaceuticals Excipients Market 2020-2030
Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others Purchase the full report or download free sample pages: https://www.visiongain.com/report/biopharmaceuticals-excipients-market-2020-2030/ The biopharmaceuticals excipients market is expected to grow at a CAGR of 12.2%. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 162-page report you will receive 85 charts- all unavailable elsewhere. The 162-page report provides
Global Biopharmaceuticals Market, Share, Growth 2019-2024
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these
Biopharmaceuticals Market Latest Trends, Analysis & Insights
The global biopharmaceuticals market is increasing, due to growing aging population. In addition, the increasing healthcare investments around the world are propelling the increase in R&D investments, which is fuelling the growth of the global biopharmaceuticals market. Furthermore, the increasing prevalence of chronic diseases due to unhealthy lifestyle, poor diet, excess alcohol consumption, and lack of physical activity is also contributing to the growth in demand of biopharmaceuticals
Emerging Trends in Biopharmaceuticals Market
Biopharmaceuticals market was valued at $186,470 million in 2017, and is projected to reach $526,008 million by 2025, growing at a CAGR of 13.8% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period. Get PDF sample copy @ https://www.alliedmarketresearch.com/request-sample/3971 Pharmaceutical companies have streamlined drug discovery and development through adoption of biopharmaceuticals. Biopharmaceuticals and therapeutic proteins have immensely aided in target-based treatment for chronic
Biopharmaceuticals and Biomedicine Market - Rapid Technical Innovation
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Biopharmaceuticals and Biomedicine Industry. Market Definition: Biopharmaceuticals has come across as one of the major segments commanding huge growth potential within the healthcare field. The high demand for effective treatment and increase in per capita healthcare expenditure has resulted in double digit revenue growth for market
Europe Biopharmaceuticals Market Report 2016
This report studies sales (consumption) of Biopharmaceuticals in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Abbott Laboratories Amgen Astrazeneca BASF Bayer Biocon Biogen Idec Boehringer Ingelheim Bristol-Myers Squibb Daiichi Sankyo Eli Lilly and Company Genentech Glaxosmithkline Hospira Johnson & Johnson LG Life Sciences Novartis Novo Nordisk Pfizer Ranbaxy Laboratories Roche Holding Sanofi Takeda Pharmaceutical Company Teva Pharmaceutical Industries UCB Market Segment by Countries, this report splits Europe into several key